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1 Abstract
The small protein α-synuclein is strongly associated with Parkinson’s disease.
This protein is found in inclusion bodies, named lewy bodies inside neurons of
people suffering from the disease. α-synuclein is very abundant in the human
brain, and its normal function is still elusive and unclear. The factors that
trigger the accumulation and fibrillation of this protein into pathogenic inclusion
bodies is of great interest in the quest of finding a cure for the disease. In this
study the isothermal fibrillation of this protein from monomeric form (found in
the brain of healthy people) into aggregated structures (found in people with
the disease) was investigated using calorimetry. This yielded insights about
the underlying thermodynamics that govern the onset and progression of the
disease. This work shows that the process of fibrillation is endothermic (needs
energy to proceed) under the investigated conditions and that calorimetry is
a method that may be employed in the study of this protein. Attempts were
made to investigate whether this protein had an effect on proton permeability
across the membrane of small unilamellar vesicles, with a pH gradient between
the interior and exterior of the vesicles. In doing so groundwork was laid for
developing a vesicle leakage assay using the lytic peptide melittin and studying
leakage through isothermal titration calorimetry.
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2 Introduction
Throughout the last decades, human life expectancy has increased dramatically[1].
During this time of rapid prolongation of our lifespan, the landscape of the
top causes of human death has shifted. Emerging among these top causes are
neurodegenerative diseases. In developed countries, Alzheimer’s disease and
Parkinson disease (PD) are now among the top 6 and 15, respectively, leading
causes of death[2, 3]. Along with an increasing elderly population, the num-
ber of people suffering from neurodegenerative diseases is likely to continue to
grow[4, 5]. More knowledge surrounding the pathogenesis of these diseases is
required to be able to design and develop new treatments that could stall or
completely prevent their fatal courses. Multiple neurodegenerative diseases is
associated with protein misfolding[6]. The main mischief makers of Alzheimer’s
disease and PD are thought to be the proteins Amyloid beta and Alpha synu-
clein (α-syn). There are many similarities between the two diseases, but to
narrow down the scope, this thesis will devote attention towards α-syn.
α-syn is a small protein consisting of 140 amino acids [7]. In solution it is con-
sidered to be intrinsically disordered [8], meaning it lacks one single stable 3-D
configuration. α-syn is highly abundant in the human brain where it makes up
1% of the cytosolic proteins in neurons [9, 10]. The normal function of α-syn is
elusive and still not well understood.
The N-terminal of α-syn (residues 1-60) include repeats of amphipathic charac-
ter, which in turn may anchor α-syn to membranes [11]. This is possible because
of the amphipathic nature of lipids themselves. The hydrophobic/hydrophilic
parts of the protein has affinity towards the hydrophobic/hydrophilic parts of
the lipids making up the membrane. Electrostatic interactions are also im-
portant for the binding. The associated entropy gain of water from burying
hydrophobic parts of the protein in the hydrophobic parts of the membranes
is also a driving force for binding. In association with membranes, the N-
terminal of α-syn adopts a highly α-helical structure [11]. The amphipathic
repeats in the N-terminal of α-syn, bear resemblance to the lipid-binding do-
main of apolipoproteins. With especially close similarity to the subclass A2
amphipathic alpha helices [12]. This resemblance is something that provides
further clues as to why α-syn has affinity towards membranes. Several studies
has shown that α-syn has a higher affinity towards membranes containing lipids
with negatively charged head groups, and in many cases does not associate, at
all, with vesicles containing only zwitterionic lipids [13, 14].
Several functions of α-syn may lie in the synaptic terminals, a compartment at
the end of the axon, containing neurotransmitters (small molecules eg. dopamine
encapsulated in small vesicles), crucial for signal propagation between neurons
in the brain. There, in the synaptic terminals, it has been suggested that α-syn
is involved in moderation of synaptic vesicle supply [15] in release of chemical
messengers [16] and the fusing of vesicles at the synapse [17]. The interaction
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of α-syn and model lipid membranes is well established, but the implications of
these interactions is not fully understood.
The aggregation of monomeric α-syn into insoluble amyloid fibrils is a process
that is thought to be the key element of PD onset and progression. Which
factors that triggers and accelerate this onset and progression is something that
has been studied excessively in vitro. The aggregation of α -syn is a nucleation
dependent process [18], which means that pre formed seeds may trigger and
accelerate the process of aggregation. α-syn fibrillation involves multiple sec-
ondary processes like fragmentation of fibrils.
Solution conditions has been shown to have an effect on the different rate con-
stants governing the kinetics of aggregation. At mildly acidic pH, the rate of
aggregation is much more rapid than at physiological pH. It has also been shown
that fibrils grow by monomer, not by oligomer addition [19]. Solution conditions
also have an effect on the sign of enthalpy associated with monomer binding to
fibril seeds. At pH 7.4 the enthalpy of fibril elongation by monomer is accom-
panied by heat absorption, at pH 2.5, the sign of enthalpy is reversed[20].
Various experimental techniques is employed to study the process of protein
aggregation. A few among the most readily used consist of different types of
spectroscopy, like circular dichroism and time-resolved fluorescence (with the
use of dyes that undergoes spectroscopic shifts upon interaction with amyloid
species). Other methods include different NMR-experiments and more morpho-
logical experiments may relay on atomic force microscopy and different scatter-
ing techniques. Each of the techniques have their advantages and disadvantages.
Everyone of them applied in vitro in the quest of better understanding the pro-
cesses happening in vivo.
Calorimetric techniques have the power to elucidate many of the underlying
thermodynamic parameters that governs the onset and progression of protein
mis-folding. In the literature, there exist a substantial body were different
calorimetric techniques are employed to study different characteristics of amy-
loid species[21, 22, 23], but only a few concerning α-syn in particular [20].
These studies often focus on the heat of denaturation of already formed aggre-
gates, or the enthalpy of heat induced aggregation in thermal up/down scans
in differential scanning calorimeters. Limited studies investigate the accom-
panied enthalpy change of the self assembly of monomeric species into fibrils,
isothermally[24]. It has been shown that the enthalpy change associated with
aggregation of β2-microglobulin is detectable through ITC[25], without per-
forming any injections during the aggregation stage, merely by monitoring the
process isothermally.
This work intend to show that the process of α-syn aggregation is a process that
is detectable through isothermal calorimetry, by monitoring the fibril formation
from monomeric species isothermally.
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3 Experimental Method
3.1 Protein purification & seed fibril formation
3.1.1 Purification of α-syn monomer
Human wild type α-syn expressed in E.coli following the procedure described
in [26], was acquired in the lab and stored at -20 ◦C during the duration of the
work.
When monomer was used, the α-syn from the freezer was always further purified
by size exclusion chromatography (SEC) through a Superdex 75 or a Superdex
75 increase column (GE Healthcare), using the experimental buffer 10 mM MES
pH 5.5. For the experiments where a higher concentration α-syn monomer was
used, multiple tubes of protein was first lyophilized and then dissolved in 6
M Guanidine hydrochloride, 10 mM MES pH 5.5, before being run through the
SEC column using the experimental buffer. The eluted monomers were collected
in low binding protein tubes and strictly kept on ice before the aggregation ex-
periments were initiated.
The protein concentrations were determined by measuring absorbance at 280
nm with a NanoDrop 2000 (Thermo scientific) and calculated with Beer Lam-
bert’s law using an extinction coefficient of 5120 M−1cm−1. (Each monomer
solution was measured a total of 9 times, 2 µL was loaded on the NanoDrop
and meassured 3 times, this process was repeated another 2 times.)
3.1.2 α-syn seed fibril formation
α-syn seed fibrils were prepared by letting α-syn monomer of known concen-
tration, purified through SEC, aggregate in low binding eppendorf tubes under
moderate stirring with a small magnetic bar. The monomers were left to fibril-
late for ≈ 48h in a 37 ◦C incubator, upon which after, insoluble fibril aggregates
were visible in the tube. The tube containing the aggregated α-syn was then
placed in a sonication bath (Struer) and sonicated for one minute. The seeds
were frozen in aliquots and stored at -20 ◦C until needed.
3.2 Vesicle preparation & size determination
3.2.1 Lipid preparation
Lyophilized lipids were purchased from Avanti Polar lipids R©. 5 mM stock so-
lutions of the different lipids were prepared through dissolving the lipids in
Chloroform:Methanol (9:1), to obtain a homogeneous distribution of lipids in
solution. Additional stock solutions of lipids with various lipid compositions, di-
verse working buffers and with individual pH was made through mixing aliquots
of lipids from the Chloroform:Methanol stock’s in glass test tubes at desired lipid
ratios. The solvent was evaporated under dry nitrogen steam in a fume hood
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and the tube was left in a vacuum dessicator over night to remove any trace of
remaining solvent. The formed lipid film was then rehydrated in the preferred
buffer and freeze thawed in 10 cycles (frozen in a dry ice/ethanol bath and
melted in 37 ◦C incubator under vigorous shaking). All stock solutions were
stored at -20 ◦C, during the duration of the work.
3.2.2 Vesicle preparation
SUV’s were prepared through sonication. 1 ml lipid suspensions, contained in
either small glass vials or eppendorf tubes were sonicated for 14 minutes, 1
second on, one second off at maximum amplitude of 8, in a soniprep 150 plus
(MSE), equipped with an exponential probe. The glass vials/eppendrof tubes
were submerged in an ice bath during sonication. After sonication, the solution
was centrifuged at 8161 RCF for 3 minutes (Biofuge 13, Baxter Heraeus), to
sediment any potential titanium debris from the sonicator probe and the vesicle
solution was transferred to a new eppendorf tube.
To obtain a pH gradient between the interior and exterior of the SUV’s, a cali-
brated amount of 1M HCl, from pure buffer, were added to the lipid suspensions.
To obtain this calibrated amount, 1M HCl was titrated into 20 mL 50 mM Tris
pH 9. HCl was added until the pH was lowered to 7.4. The amount HCl re-
quired to lower the 20 mL solution form 9 -> 7.4, was divided by 10 and added
to 2 mL solution containing the vesicles prepared in 50 mM Tris pH 9. This
procedure was also carried out for vesicles prepared in 10 mM MES pH 6.7,
in that case 1M HCl was added to lower the pH to 5.5. The influence of the
vesicles themselves, on the pH were not accounted for.
3.2.3 Size determination of vesicles
The size of the SUV’s were determined through nano tracking analysis (NTA)
with a Nanosight LM10, (Malvern instruments). This method yields both size
and concentration distribution of vesicles in suspension. These characteristics
are obtained by sending a laser beam through the vesicle suspension. Subse-
quently, vesicles in the path of the laser beam scatter light. The scattered light
is then visualized in a microscope. The movement/diffusion of vesicles, due to
Brownian motion, is recorded with a camera mounted on the microscope. From
this recording, a software tracks individual vesicles movement, and through the
Stokes-Einstein relation, calculates the vesicles hydrodynamic radius.
When SUV’s are prepared through freeze thawing and sonication, the vesicles
will be polydisperse, meaning there might even be large unilamellar vesicles
present in the solution. Larger vesicles could introduce bias in the size determi-
nation, because they scatter more light than smaller vesicles. This risk is fairly
low because the vesicle suspensions were significantly diluted prior to analysis
to reduce the number of particles. The LM10 requires samples with a concen-
tration ranging from 106 to 109 particles per mL, to able to distinguish and
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accurately track, individual particles.
3.3 Calorimetry
Calorimetric measurement was performed in a VP-ITC,VP-DSC and Peaq-ITC
(Malvern instruments). All samples used in the VP instruments were degassed
under stirring and thermostatted to ≈ 25 ◦C for 10 minutes in a Thermovac
(Microcal), before being loaded in the sample cells (or the injection syringe of
the ITC). For the seeded/vesicle induced aggregation experiments of α-syn, the
monomer was first degassed for approx 5 minutes before the vesicles/seeds were
mixed in with the monomers and degassed for another 5 minutes.
For further information about cell loading and general operation of the instru-
ments, consult the user manual of the three calorimetersABC.
3.3.1 Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) is a widely used technique to character-
ize the thermodynamics parameters of binding between two (or more) species
in solution, eg. protein-ligand. The main components of an ITC is a sample
and reference cell and an injection syringe. The sample and reference cell is
separated by a peltier element to have maximum heat conductivity between the
cells. During the measurement a small current is supplied to the reference and
sample cell heaters, to maintain the cells at a constant temperature and ∆T=0
between the cells. Known amounts of ligand is injected into the sample cell
containing the protein. The resulting enthalpy change associated with binding
of the ligand to the protein is then detected as a power differential (DP) needed
to maintain the sample and reference at the same temperature. Depending on
the sign of enthalpy of binding between protein in ligand, the DP will either
deflect in positive or negative direction. When the heat, either absorbed or
evolved in the sample cell has equilibrated with the reference cell, the DP will
return to the baseline. The DP is converted and reported as µCal/s. When the
resulting peak from an injection is integrated with respect to time and normal-
ized with respect to the number of moles ligand injected, the molar enthalpy of
binding is obtained. As the binding sites on the protein in the sample cells gets
saturated with ligand, the enthalpy of binding decreases gradually with each
new injection, until the protein is fully saturated and the observed ∆DP is only
due to the enthalpy of dilution of the ligand. From the corresponding thermo-
gram the enthalpy (from the normalized integrated peak of the first injection
when all injected ligand binds to the protein), binding affinity (from the slope
of the decreasing DP signal) and stoichiometry (from the midpoint of the slope
Ahttp://www.malvern.com/Assets/MicroCal-VP-DSC-system-operating-instructions-
English-MAN0568-01-EN-00.pdf
Bhttp://www.malvern.com/Assets/MicroCal-VP-ITC-system-operating-instructions-
English-MAN0569-01-EN-00.pdf
Chttp://www.malvern.com/Assets/MicroCal-PEAQ-ITC-user-manual-English-MAN0573-
02-EN-00.pdf
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if binding is 1:1) of the binding reaction is obtained, subsequently the entropy
and Gibbs energy of the reaction is also obtained.
When performing ITC a buffer with a low ionization enthalpy is preferred, this
to reduce the effects of buffer mismatch. Normally the same buffer is used for
the solute in the syringe and in the sample cell. If these buffers have slightly
different pH, the enthalpy change of the corresponding ionization of the buffer,
following injection will affect the observed enthalpy change associated with bind-
ing. Often dialysis is performed on both the species, to ensure that the buffers
they are dissolved in have the exact same pH. This reduces the potential of the
enthalpy change corresponding from injection of a buffer with one pH into a
buffer with a different pH. If there is a buffer mismatch between the buffer used
in the syringe and the one used in the sample cell, the ionization enthalpy have
the potential to transcend the enthalpy change of binding when performing ITC.
In this work the capabilities of ITC is exploited, not to observe binding of lig-
and to macromolecule, but rather to investigate whether ITC may be used to
detect the permeability of protons across the lipid bilayer of vesicles. In doing
so, a buffer with a high ionization enthalpy is working in the advantage of the
experimental design.
This was done by injecting the peptide melittin (which is known to cause mem-
brane permeability) into the sample cell containing SUV’s with a pH gradient
between the interior of the vesicles and the exterior bulk solution.
The enthalpy change of α-syn fibrillation was also monitored in the ITC. Both
by injecting an aliquot of preformed α-syn seeds into the cell containing α-syn
monomer and by having seeds/monomer premixed in the sample cell.
The experimental procedures differed slightly between those experiments per-
formed in the VP-ITC and those in the PEAQ-ITC. The VP-ITC has a max-
imum time spacing between each injection of ≈ 24h, while in the PEAQ-ITC
only ≈ 2.8h. The injection of seeds was usually performed after an initial delay,
followed by the maximum time spacing for the different instrument. Consult
each figure text for further details.
The peaks corresponding from injections were integrated and analyzed in Origin
7.0 for those experiments performed in the VP-ITC and MicroCal PEAQ-ITC
analysis software for the experiments conducted in the PEAQ-ITC.
3.3.2 Differential scanning calorimetry
Differential scanning calorimetry (DSC) is a technique that may be used to
study the enthalpy and heat capacity change accompanying a wide range of
thermal transition of species in solution, e.g. it may be used to study the ther-
mal stability of biomolecules when heated, or the cold denaturation of proteins.
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The arrangement of the instrument is similar to the ITC, where the DP between
the sample cell and reference is reported to the user. But instead of measuring
the accompanied change in DP from an injection, the DSC measures the change
in DP upon heating/cooling both the cells. In a typical protein denaturation
experiment, the protein is loaded in the sample cell and the experiment buffer
is loaded in the reference cell. A constant power is supplied to heat both cells in
a synchronized manner. When the cells reaches the temperature of transition,
e.g. where the protein starts to unfold. The energy needed to maintain the cells
at same temperature will start to differentiate as a consequence of the change
in heat capacity and the associated enthalpy change of the protein as it unfolds.
During this work, only isothermal scans at 37 ◦C was performed in the DSC.
4 Results
4.1 Fibrillation of α-syn
The process of α-syn fibrillation was monitored isothermally through calorime-
try, in a VP-DSC, VP-ITC and a PEAQ-ITC. This was done to investigate the
thermodynamic properties associated with the self assembly of monomeric α-syn
into aggregated fibrillar structures. Performing these scans isothermally yields
insight about the enthalpy change accompanying this process. The concentra-
tion of α-syn monomer and seeds used, were varied throughout the different
scans. Depending on which instrument that was used, the seeds and monomer
were either pre mixed or the seeds were injected into the cell containing the
monomer, once the scan had begun. Figure 1 (a-d) shows the change in DP
over time for the process occurring when monomer was incubated with seeds
in a DSC. After the scans, the samples were collected in eppendorf tubes and
insoluble aggregates was visible in all 5 experiments. The reason for only per-
forming one 16 hour scan in figure 1(c) was to confirm that fibrils were visible
after the peak between 200 & 600 min had occurred. The same monomer/seed
solution used in figure 1(b), was also scanned in a PEAQ-ITC see figure 11(b)
in appendix 1. The scan performed in the PEAQ-ITC did not display the same
characteristics, with a clear peak as seen in the scans performed in the DSC.
Figure 2 and in appendix 1; figure 11(a) & 12(e)-(f), shows the isothermal scan
of monomer incubated with different vesicles, with and without a pH gradient
between the interior and exterior of the vesicles. Figure 3 & 4 and in appendix
1; figure 10, 13 and 14 shows the isothermal scans of α-syn monomer incubated
with and without seeds.
Consult each individual figure caption for a more in depth review of the different
experiment parameters.
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Time [min]
0 200 400 600 800 1000
D
P 
(m
Ca
l/m
in)
0.035
0.04
0.045
0.05
0.055
Seeded fibrillation of α  -syn
Scan 1
baseline
Scan 2
Scan 3
Q = 1172 µCal
(a)
Time [min]
0 200 400 600 800 1000
D
P 
(m
Ca
l/m
in)
0.035
0.04
0.045
0.05
0.055
Seeded fibrillation of α  -syn
Scan 1
Baseline
Scan 2
Scan 3
Q = 902 µCal
(b)
Time [min]
0 200 400 600 800 1000
D
P 
(m
Ca
l/m
in)
0.035
0.04
0.045
0.05
0.055
Seeded fibrillation of α  -syn
Scan 1
Baseline
Q = 1113 µCal
(c)
Time [min]
0 200 400 600 800 1000
D
P 
(m
Ca
l/m
in)
0.035
0.04
0.045
0.05
0.055
Seeded fibrillation of α  -syn
Scan 1
Baseline
Scan 2
Q = 1377 µCal
(d)
Time [min]
0 200 400 600 800 1000
D
P 
(m
Ca
l/m
in)
0.0345
0.035
0.0355
0.036
0.0365
0.037
0.0375
0.038
0.0385
Seeded fibrillation of α-syn
data1
data2
data3
data4
data5
data6
data7
(e)
Figure 1: (a-d) Shows isothermal scans of the seed induced fibrillation of α-
syn. In the sample cell: 134 µM α-syn monomer, 2 µM seeds, in 10 mM MES,
0.01% NaN3 pH 5.5. Pure buffer was used in the reference cell. The scans were
performed at 37◦C, 27±1 Psi, low feedback mode, with a filtering period of 25
s. The baselines were fitted locally through a baseline session in Origin 7.0. The
peaks were integrated and the integrals are displayed as Q in each graph. The
monomer used in each set of scans (a-e), was purified separately, just prior to
each scan. The only thing different in (e) is that a filtering period of 5 s was
used.
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4.1.2 Monitored in VP-ITC
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Figure 2: (a) shows the isothermal scan of 39 µM α-syn monomer incubated at
37◦C in 10 mM MES, 0.01% NaN3, pH 5.5. The syringe was loaded with buffer
and a 1 µL injection was performed after 24h. The scan was stopped and the
syringe reloaded with 36 µM seeds. The scan was started again (b), after a 2h
initial delay 40 µL seeds were injected in the same monomer solution as in (a),
to a final cell seed concentration of 1 µM. The corresponding injection peak is
magnified and displayed as a subplot in (b).
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Figure 3: Shows the isothermal scan of 26 µM α-syn monomer incubated at 37
◦C and the injection of 40 µL 36 µM seeds to a final cell seed concentration of 1
µM. Figure (a) contains a subplot of the corresponding injection peak and (b)
is a zoom in of the scan.
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Figure 4: (a)&(b) shows the isothermal scans, performed at 37 ◦C. In the
sample cell: 24 µM α-syn monomer incubated with 0.17 mM sonicated
DOPC:GM1(9:1), in 10 mM MES, 0.01% NaN3, pH 5.5. The syringe was loaded
with 10 mM MES, 0.01% NaN3, pH 5.5, 1 µL injections was performed every
24h. A temperature drift had occurred in scan (a) and the temperature was
38.4 ◦C when the scan was stopped after ≈ 120h. The monomer and vesicles
used in (a)&(b) was purified and prepared separately.
4.2 Vesicle leakage
4.2.1 Melittin induced vesicle leakage
The concentration of melittin injected into the vesicle solutions was varied
throughout these experiments. The vesicle concentration was also changed back
and fourth, in an attempt to find a ratio between vesicle and melittin where com-
plete leakage of the vesicles internal solution could be observed. Many of the
different ratios was investigated both with a pH gradient between the interior
and exterior of the vesicles, but also with the same pH inside and outside. In
the plot legends where only Tris is annotated, corresponds to 50 mM Tris, 0.2%
EDTA, 0.02% NaN3 pH 7.4. This is the working buffer for all experiments per-
formed with melittin.
Figure 5 show the corresponding change in DP from injecting 75 µM melittin
into different concentrations DOPC:DOPS (3:1), with and without pH gradi-
ent. Figure 6(a)&(b) show the size distribution of the vesicles before and after
injection of melittin of two of the injection series in figure 5.
Figure 7(a) & (b) show injections of different concentrations of melittin into 1.5
mM DOPC:DOPS (3:1), with a pH gradient between the interior and exterior
of vesicles in (a) and the same pH inside and outside in vesicles in (b). Figure
8 show the size distribution before and after injection of melittin in the vesicles
used in 7(a). Table 1 show the integrated peaks of the injections carried out in
figure 7(a).
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Additional experiments where melittin were injected into vesicles may be found
in appendix 2; Figure 15(a), show injection of decreasing concentrations melittin
(100µL, 50µL, 25µL, 10µL) in 1.5 mM DOPC:DOPS (3:1) with a pH gradient.
Figure 16 show the injection of 0.3 mM melittin into 0.5 mM vesicle solution.
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Figure 5: Show the corresponding change in DP from injecting the same volume,
25 µL, 75 µM melittin into: In blue; 0.5 mM vesicles with pH gradient. In
orange; 1 mM vesicles no gradient. In yellow; 0.1 mM vesicles with pH gradient.
In purple; Tris pH 7.4. In green; Tris adjusted from pH 9 to 7.4 in the same way
as the gradient in the vesicle solutions. All vesicles used were DOPC:DOPS
(9:1), the experiments were performed at 37 ◦C with 307 RPM stirring in a
VP-ITC. An offset in y-direction, has been added to each dataset for better
visualization of the peaks.
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Figure 6: Show the size distribution of vesicles before adjusting pH outside of
vesicles to 7.4, after adjusting pH and after injecting melittin into vesicles. The
vesicles investigated is the ones used in figure 5. (a) show the size of vesicles
before and after injection of melittin in the same vesicles as those used in the
blue curve of figure 5. (b) show the vesicles used in yellow curve of figure 5.
The vesicles were diluted to 1.5 µM before NTA was performed.
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(a) pH 9 inside, 7.4 outside vesicles.
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(b) pH 7.4 inside and outside vesicles.
Figure 7: Show the corresponding change in DP from injecting the same volume,
5µL melittin of different concentrations, into a constant concentration of 1.5 mM
DOPC:DOPS (3:1). The vesicles used in (a) has a pH gradient, pH 9 inside,
7.4 outisde. The vesicles in (b) has the same pH, 7.4 inside and outside. The
experiments were performed at 37◦C, 500 RPM stirring in a PEAQ-ITC. A
phase shift has been added to the data in (a), (Time of first injection + n
minutes (n=0,1,2,3). The data for injection of melittin in Tris has rather been
added an vertical offset, for better visualization.
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Figure 8: Show the size distribution of vesicles before adjusting pH outside of
vesicles to 7.4, after adjusting pH and after injecting melittin into vesicles. The
vesicles investigated is the ones used in figure 7(a). The vesicles were diluted to
1.5 µM before NTA was performed.
Table 1: Show the raw heat corresponding from injection of different concentra-
tions melittin into 1.5 mM DOPC:DOPS (3:1) pH 9 inside, 7.4 outside vesicles.
The different raw heats are integrals of the peaks in figure 7(a).
100 µM 300 µM 3 mM 6 mM 3 mM in Tris
Inj nr ∆ Q (µcal) ∆ Q (µcal) ∆ Q (µcal) ∆ Q (µcal) ∆ Q (µcal) Vol. (µL)
1 -4.7 -3.4 -3.2 -1.7 -0.076 0.400
2 -108.9 -84.6 -54.9 -31.4 -0.88 5.00
3 -103.1 -79.9 -51.6 -27.9 -0.76 5.00
4 -96.4 -75.2 -46.5 -30.1 -0.62 5.00
5 -91.1 -70.7 -39.9 -25.5 -0.61 5.00
6 -85.7 -66.4 -36.2 -23.5 -0.54 5.00
7 -80.3 -62.4 -36.0 -22.5 -0.44 5.00
8 -75.5 -58.8 -34.2 -21.5 - 5.00
4.2.2 α-syn induced vesicle leakage
To investigate whether α-syn had an effect on proton permeability of vesicles,
similar to that of melittin, α-syn monomer was injected into vesicles. Figure 9
show the corresponding change in DP from injections of 155 µM monomeric α-
syn into 1.5 mM DOPC:DOPS (3:1). Table 2 show the raw heat corresponding
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from the injections in figure 9.
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Figure 9: Show the change in heat flux corresponding from injection of α-syn
in vesicle solutions. 155 µM α-syn was loaded in the injection syringe and 1.5
mM sonicated DOPC:DOPS (3:1) in the sample cell. An initial injection of 0.4
µL followed by 7 injections of 5µL was performed. In blue; vesicles with pH 6.7
inside and 5.5 outside was used. In orange; vesicles with 5.5 inside and outside
was used. In yellow; α-syn was injected into MES pH 5.5. The experiment was
performed at 37 ◦C with 500 RPM stirring in a PEAQ-ITC.
Table 2: Show the raw heat corresponding from injection of α-syn monomer in
vesicles with and without a pH gradient between the interior and exterior of the
vesicles. The different raw heats are integrals of the peaks in figure 9.
pH Diff Same pH MES
Inj nr ∆ Q (µcal) ∆ Q (µcal) ∆ Q (µcal) Vol. (µL)
1 -1.31 -2.09 -0.04 0.400
2 -36.20 -34.82 -0.52 5.00
3 -6.04 -3.51 -0.47 5.00
4 -0.51 -2.00 -0.13 5.00
5 -0.40 -1.85 -0.63 5.00
6 -1.06 -2.29 -0.60 5.00
7 -1.11 -2.12 -0.61 5.00
8 -1.23 -2.00 -0.54 5.00
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5 Discussion
The main questions behind this work was whether the spontaneous and seed/vesicle
induced aggregation of α-syn was detectable through calorimetry. These ques-
tions were prompted by unpublished, preliminary results obtained by Erik Hell-
strand, 2012. A second underlying question throughout this work was whether
α-syn vesicle co-aggregation would disrupt the vesicle bilayer and cause proton
leakage across the membrane. To be able to quantify the extent of protons
leaking across the vesicle bilayer, a series of ITC experiments where melittin
was injected into vesicles with alternating pH inside and outside vesicles was
performed.
5.1 α-syn fibrillation
To investigate the accompanying enthalpy change associated with the fibril for-
mation of α-syn monomer, monomer in the 30 µM range was incubated at 37◦C
in a VP-ITC. These scans yielded limiting results and as a consequence, scans
of monomer with vesicles and seeds present were performed. After a series of
experiments yielding vague data of the enthalpy change of the fibrillation pro-
cess, the concentration of α-syn was significantly increased to 134 µM and a
scan with seeds present were performed in a VP-DSC, see figure 1(e), where
seven, ≈16.5h consecutive isothermal scans of the same monomer solution was
performed. Interestingly the first scan, in blue, showed a different slope than
the 6 succeeding scans. Different moving average filters were applied to the
data, in an attempt to better elucidate the change in signal and possibly to vi-
sualize a peak. The data treatment managed to reduce the signal to noise ratio,
but a clear peak was not made distinguishable from what as easily could have
been a drift in baseline and due to instrumental detection limits. The filtering
period used for this first experiment in the DSC was five seconds. This is the
setting for over which time interval raw data is averaged and a data point is
stored, for a sharp transition eg. the phase transition of lipids when heated,
requires frequent sampling of raw data to resolve the peak of transition. The
isothermal aggregation of α-syn is a much slower process, and therefore frequent
sampling of the raw data of the process possibly introduce unnecessary noise
in the data set. When the filtering period was changed to 25s, figure 1(a)-(d),
clear transition peaks were visible for the other scans performed with the same
concentration monomer and seed as figure 1(e).
Interestingly, the observed enthalpy change for the processes taking place dur-
ing the first scan in figure 1(a)-(e) is endothermic. (a common misconception is
that a positive peak in a DSC or ITC thermogram is exothermic, this is not the
case. When heat is consumed in the sample cell, the heat flux (DP) increases
to compensate for the thermal difference between the cells). It is compelling to
think that the response of the signal in figure 1(a)-(d) is due to the fibril for-
mation of α-syn. If this is the case, the observed peak in the isothermal scans
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in 1(a)-(d) is probably arising from the much more rapid secondary nucleation,
than the slower primary nucleation of α-syn monomer. Other processes taking
place during the scan, like fragmentation of fibrils and monomer binding to fib-
rils are also things that influence the overall observed enthalpy change in the
scans. Precipitation of insoluble fibrils is also something that might cause bias
and artifacts in the measurements, when they presumably falls to the bottom
of the sample cell and comes in contact with the cell bottom. This is somthing
that is likely to change the heat capacity of the system.
If the process of fibril formation is endothermic under the investigated condi-
tions, it means that the overall process is entropy driven, in the light of the
relation ∆G = ∆H −T∆S, where ∆G must be negative for a reaction to occur
spontaneously. On one hand one could argue that the reaction is not occurring
spontaneously due to the fact that it is catalyzed by pre formed fibrils, and
on the other hand one could state that these fibrils would have formed them-
selves given time. It would have been interesting to perform a longer scan of
only monomeric α-syn at the same concentration, to see what the corresponding
thermogram would look like in the DSC.
Working with the view that the overall process of fibrillation is endothermic
means that the gain in entropy of the system must overcome this positive change
in enthalpy, for the process to proceed. The entropy of the protein itself, go-
ing from monomeric form to aggregated form is probably decreasing, but the
burial of hydrophobic side chains within the fibril cores is something that could
increase the system’s overall entropy, by increasing the entropy of water (by dis-
rupting the coordination spheres around the hydrophobic parts of the protein).
In the study where mature α-syn fibrils were denatured by thermal up scans
performed by DSC [20], the corresponding thermogram exhibited an exothermic
peak for the denaturation of the fibrils. The authors further suggests a positive
enthalpy change for the formation of α-syn fibrils, something that agrees with
the thermograms obtained for the fibril formation observed in this thesis 1(a)-
(d). The time for when the peaks occurred is also within the same range as seen
in other seeded α-syn kinetic experiments using orthogonal methods (eg. Tht
fluorescence in a plate reader [27]).
The spontaneous fibrillation of 39 µM α-syn was monitored in a VP-ITC, see
figure 2(a), after ≈25h seeds were added to a final concentration of 1 µM see
figure 2(b). For the scan in (a) there is no visible peak indicating fibrillation.
The filter period used in these scans were two seconds, and from the earlier
statement made surrounding the filter period. The fibrillation might not even
be distinguishable from the baseline using such a frequent data sampling time
constant. If no fibril formation occurred in (a), the peak corresponding from
injection of seeds into the solution in (b) gives insights about the enthalpy of
binding of monomer to fibril. Another scenario is that the monomer had already
fibrillated and the injection peak in (b) is caused by the dilution enthalpy of the
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seeds injected.
The scans where seeds were injected into α-syn monomer, were not designed
to investigate the associated binding of monomer to fibril, but rather to inves-
tigate the fibrillation process. However from the injection peaks where seeds
were injected into monomer, the overall tendency of the elongation (monomer
binding to fibril) seems to be exothermic. The injection of seeds in figure 3(a)
display both an exothermic followed by an endothermic signal. This might be
because of a more complex process than only monomer binding to fibril. The
endothermic tail of the injection may also have been caused by a small bub-
ble. When performing binding experiments with ITC, usually the injections are
initiated with a small first injection to dislodge the potential little air bubble
present at the tip of the injection syringe. Figure 10(a) in appendix 1, also
contain this similar endothermic tail, when seeds were injected into monomer,
but the overall character of the injection peak is exothermic. Figure (b) is a
magnification of the scan following the injection of seeds, and although the scan
is quite "spiky", a small change in heat capacity of the system is observed ≈
200 minutes after the injection is made and lasting for 250 minutes before the
baseline becomes stable. This is within the same range as the peaks observed in
figure 1(a)-(d) and could possibly be a consequence of aggregation. The same
small divination in the signal is also observable in figure 3(b) between 9 and 14
hours, approximately 9 hours after injection.
In figure 4(a) & (b), 24 µM α-syn were incubated with 0.17 mMDOPC:GM1(9:1)
vesicles, same pH inside and outside vesicles, figure (b) bear the resemblance
of the peaks obtained in 1(a)-(d), however no distinct baseline is present before
the peak starts evolving. This could maybe have been avoided by injecting the
vesicles into the monomer solution, once a steady baseline was obtained, rather
than having them pre mixed in the sample cell. The scan in (a) displays a pecu-
liar characteristic, maybe due to a dirty cell/syringe, which alters the systems
heat capacity. Since (b) did not display the similar tendency the data generated
is probably due to some artifact.
When monomer was incubated with SUV’s, with a higher pH inside than out-
side, figure 11(a) & 12(e)-(f) appendix 1., a small exothermic deviation is ob-
served in the baseline after approximately 1000 minutes in both cases. If this
change was due to monomer interacting with the bilayer or whether the leakage
is caused by the SUV’s rearranging themselves, into larger structures, is hard to
tell. To further investigate the possible lytic effect of α-syn on vesicles, α-syn
monomer were injected into SUV’s with and without a pH gradient, figure 9.
The area of the injection peaks decreases rapidly with the first injection. There
is no significant difference between the area of the peaks were monomer is in-
jected into SUV’s with pH gradient than those without. This indicates that
significant leakage is not observed. Interestingly though, is the fact that the
peaks are decreasing quickly, this could mean that there exist a few preferential
binding sites on the vesicles, which gets saturated quickly with the first injec-
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tions. Possibly domains of negatively charged lipids or other structural features
of the vesicles, size or curvature which promote binding of monomer.
5.2 Melittin induced vesicle leakage
An attempt was made to develop a method for investigating vesicle leakage us-
ing ITC. The lytic peptide melittin was injected into vesicle solutions with and
without a pH gradient between the interior and exterior of the vesicles. In these
experiments Tris was used because of its relatively high ionization enthalpy;
TrisH+ ⇀↽ Tris+H+, ∆Hion = ±47.45kj ·mol
−1 at 298.15 K [28]. The idea
behind this method was to inject melittin into a solution of SUV’s, and cause
leakage of their internal solution. By having a higher pH inside the SUV’s than
outside, the internal solution would upon leakage be protonated, and the pro-
tonation enthalpy measured by ITC.
As expected the observed enthalpy change for injecting melittin into SUV’s with
a pH gradient was greater than for those without. Something that might inter-
fere with this observation is the possibility that when a pH gradient is present
between the interior and exterior of the SUV’s the enthalpy of binding of melittin
to vesicles might be altered. The negatively charged head-group lipids, DOPS,
might have preference for the outer layer of the bilayer, facing the more acidic
outer solution [29]. To rule the possibility of this out and to investigate whether
this might be a scenario, the experiments could have been performed with vesi-
cles containing only zwitterionic DOPC.
Figure 5 show the injection of 75 µM, 25 µL aliquots melittin into SUV’s
DOPC:DOPS (3:1). When melittin were injected into 0.5 mM SUV’s with
a pH gradient (blue data set). The two first injection enthalpies are close to
identical. The following injections, result in a gradually decreasing signal. The
signal does not decrease to the size of injecting melittin into vesicles without
a pH gradient (orange). One reason for not observing full leakage might be
because of new melittin injected binds to vesicles which have already leaked.
When the SUV concentration was decreased to 0.1 mM, with a pH gradient,
the observed DP for injection of melittin was close to that of injecting melittin
in SUV’s, without a pH gradient and also close to that of injecting melittin in
buffer without SUV’s. The injection of melittin into the experimental buffer
pH 7.4 (violet), and the injection of melittin into buffer pH 9 adjusted to pH
7.4 in the same manner as the SUV solutions, provides insights about how ac-
curate the pH adjustions were. Figure 6(a)&(b) show the size of the vesicles
before and after pH adjustment, and after injection of melittin into 0.5 mM
and 100 µM vesicle solutions, same vesicles as those in figure 5. The mean
size is distributed around 100 nm, in (a) the size of the vesicles are slightly
decreased when a pH gradient is introduced. Having a higher concentration H+
outside the vesicles will probably cause an osmotic pressure and there will be
a potential for water to exit the vesicles, and this may explain the shrinkage
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of the vesicles. After melittin is injected the size slightly increases again. The
trend is not the same in (b), here the size is slightly larger after pH adjustments.
To further investigate the effects of pH gradient on the size of vesicles, exper-
iments focusing solely on the size could be performed. It would have been
interesting to perform multiple size determinations at fixed time intervals after
sonication, to get a clearer picture on how fast SUV’s rearrange themselves into
larger structures.
Since full leakage of the SUV’s internal solution was not observed after injecting
melittin into varying SUV concentrations, the vesicle concentration was fixed
and the melittin concentrations varied. Figure 7(a) show the injection of 5
µL melittin aliquots of 100 µM, 300µM, 3 mM, 6mM in 1.5 mM SUV’s with
a pH gradient. Increasing the melittin concentration was thought to increase
the observed leakage, but rather the observed change in DP decreased with an
increased melittin concentration. This promoted the idea that melittin might
react with itself, this could have been further investigated by injecting melit-
tin into melittin. Another explanation for this behavior is the possibility that
protons leaks across the bilayer spontaneously. The same SUV’s were used for
all the experiments in figure 7(a), starting with injection of 100 µM melittin
shortly after sonication and pH adjustment. Approximately one hour passed
before the next higher concentration melittin was used. The difference in ionic
strength between the interior and exterior of the SUV’s might have the potential
of causing them to leak, and perhaps the redistribution from smaller size vesi-
cles into larger happened during the experiment. The stirring of the solutions
during the ITC experiments might also be something that have the potential
of agitating and to cause a size redistribution, leading to bias in the experiments.
The experiment was repeated but instead of increasing the melittin concentra-
tion from 100 µM and upwards, the concentration was decreased from 100 µM.
Figure 15(a) in appendix 2. Interestingly, the injection of 100 µM melittin in
figure 15(a) yielded a much lower observed enthalpy change than the injection
of 100 µM melittin in figure 7(a). This might display some of the problems with
repeatability in the experimental design. The injections of 100, 50, 25 and 10
µM melittin in figure 15(a) was in the size range of injecting melittin in pure
buffer. A different explanation for this might be that the melittin used in figure
15(a) was degraded or aggregated, or the experiment were subject so some other
type of contamination.
Figure 17 in appendix 2 show the injection of 7.9 mM melittin into 0.1 mM
SUV’s (blue), all the melittin is thought to bind to the vesicles, because no
decrease in signal is observed. The melittin concentration was doubled and in-
jections were continued into the same SUV’s. This caused a gradual decrease
in signal, likely from saturation of binding sites on the SUV’s.
All the experiments where melittin were injected in SUV’s were performed at
22
37◦C. Because the high pH temperature dependence of Tris, and the fact that
the pH was adjusted at room temperature is something that has introduced
errors throughout the experiments.
6 Conclusions
This work shows that the isothermal seeded fibrillation of α-syn is detectable
through calorimetry. Further work would include performing isothermal scans of
SUV’s incubated with α-syn monomer, using the same instrumental settings as
where fibrillation was observed. Introducing a pH gradient between the interior
and exterior of the co-incubated SUV’s might have the potential to elucidate to
which degree the coaggerigation might distrupt the SUV’s bilayer.
Groundwork has been laid in the development of a new vesicle leakage assay
using ITC. Further work lies in finding a ratio between lytic species and vesicles
to a point where full leakage may be observed.
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7 Appendix 1
7.1 Additional isothermal scans of α-syn fibrillation
7.1.1 Monitored in PEAQ-ITC
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Figure 10: (a)&(b) Shows the isothermal scan of 28 µM-syn monomer incubated
at 37◦C and the injection of 20µL 15µM seeds to a final cell seed concentration
of 1µM. (b) is a zoom in of the scan after injection of seeds.
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Figure 11: Show isothermal scans performed at 37 ◦C without stirring in a
PEAQ-ITC. In (a) 35 µL, 4.47 mM sonicated DOPC:DOPS (3:1), pH 6.7 inside
vesicles, 5.5 outside is injected into the sample cell containing α-syn monomer
to a final cell concentration of 0.5 mM vesicles and 25 µM monomer. 0.1 µL
injections of vesicles were performed every 2.8 hour. Figure (b) show the scan
of the same sample used in 1(b), In the sample cell: 134 µM α-syn monomer, 2
µM seeds. 0.1 µL injections of buffer were performed every 2.8 hour. The buffer
used in both runs; 10 mM MES, 0.01 % NaN3 pH 5.5.
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7.1.2 Monitored in VP-DSC
α-syn vesicle co-aggregation
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Figure 12: (a-f) shows 6 consecutive isothermal scans, of the same sample.
In the sample cell: 24.5 µM α-syn monomer, 0.5 mM sonicated DOPC:DOPS
(75%:25%, pH 6.7 inside SUVs, pH 5.5 outside.) in 10 mM MES, pH 5.5.
Degassed milli Q water was used in the reference cell. The scans were performed
at 37◦C, using isothermal scan mode, a filtering period of 5 sec and low feedback
mode.The monomer used in the scans had been stored on ice for two days prior
to scan nr. 1.
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7.1.3 Monitored in VP-ITC
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Figure 13: (a)&(b) Shows the isothermal scans of 30 µM-syn monomer incu-
bated at 37◦C
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Figure 14: Shows a less optimal scan of 30 µM-syn monomer incubated at 37◦C,
the cause of the noisy signal could be a trapped air boubble or a dirty cell. This
scan show how important proper degassing and sample preparation is.
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8 Appendix 2
8.1 Melittin induced vesicle leakage
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Figure 15: (a) Shows the corresponding change in DP from injecting the same
volume, 5 µL melittin of different concentrations, into a constant concentration
of 1.5 mM DOPC:DOPS (3:1) pH 9 inside, 7.4 outside vesicles. The experiments
were performed at 37 ◦C, 500 RPM stirring in a PEAQ-ITC. (b) shows the size
of vesicles before and after pH was adjusted, and after injection of 100 µM
melittin.
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Figure 16: Shows the corresponding change in DP from injecting 12.5µL
aliquots, 0.3 mm melittin into 0.5 mM sonicated DOPC:DOPS (3:1) pH 9 in-
side, 7.4 outside vesicles.The experiment was performed at 37◦C,with 307 RPM
stirring in a VP-ITC.
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Figure 17: Shows the corresponding change in DP from injecting in blue 7.9
mM melittin, red 13.6 mM melittin into 0.1 mM DOPC:DOPS (3:1) same pH
inside and outside vesicles. First 25 µL aliquots of 7.9 mM were injected(blue),
after the injections, excess solution was removed from the ITC sample cell. The
syringe was reloaded with 13.6 mM melittin and 25 µL aliquots was injected
(red) into the same vesicle solution as before. The experiment was performed
at 37◦C,with 307 RPM stirring in a VP-ITC.
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